1	Añadir	añadir	VMN0000	-	-	0-6	155(2)_ANS_clinical_caseMIR	SENT1	-	-
2	omalizumab	omalizumab	NC00SC0	C0966225	producto#sustancia	7-17	155(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
3	.	.	Fp	-	-	18-19	155(2)_ANS_clinical_caseMIR	SENT1	-	-

